Loading clinical trials...
Loading clinical trials...
German: Einfluss Von Airtrapping Auf Atmung Und Schlaf Bei Nichtinvasiver Beatmung (NIV) Von COPD Patienten
15 COPD patients will be surveyed in this prospective randomized crossover pilot study concerning non invasive ventilation. Patients will be treated over 2 nights in randomized order with Ventimotion2 (Weinmann) with and without Airtrap Control under Polysomnography (PSG) surveillance including transcutaneous pCO2 measurement. The sleep quality is judged by evaluating the PSG and pCO2 values over night. Target parameters are respiratory rate, sleep quality and influence of Airtrap Control on pCO2 values over night.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Helios Klinik Hagen
Hagen, North Rhine-Westphalia, Germany
Start Date
October 1, 2013
Primary Completion Date
March 1, 2018
Completion Date
March 1, 2018
Last Updated
February 11, 2019
10
ACTUAL participants
BIPAP ST
DEVICE
Airtrap
DEVICE
Lead Sponsor
Institut für Pneumologie Hagen Ambrock eV
Collaborators
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions